nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—ALB—Captopril—systemic scleroderma	0.144	0.315	CbGbCtD
Clonazepam—ALB—Mycophenolate mofetil—systemic scleroderma	0.113	0.248	CbGbCtD
Clonazepam—ALB—Prednisone—systemic scleroderma	0.0904	0.198	CbGbCtD
Clonazepam—ALB—Methotrexate—systemic scleroderma	0.0454	0.0994	CbGbCtD
Clonazepam—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0355	0.0777	CbGbCtD
Clonazepam—CYP3A4—Prednisone—systemic scleroderma	0.0283	0.0621	CbGbCtD
Clonazepam—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000649	CcSEcCtD
Clonazepam—Diarrhoea—Captopril—systemic scleroderma	0.000352	0.000647	CcSEcCtD
Clonazepam—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000351	0.000647	CcSEcCtD
Clonazepam—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000646	CcSEcCtD
Clonazepam—Irritability—Methotrexate—systemic scleroderma	0.000351	0.000646	CcSEcCtD
Clonazepam—Erectile dysfunction—Prednisone—systemic scleroderma	0.00035	0.000645	CcSEcCtD
Clonazepam—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000644	CcSEcCtD
Clonazepam—Feeling abnormal—Leflunomide—systemic scleroderma	0.000349	0.000643	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000349	0.000642	CcSEcCtD
Clonazepam—Fatigue—Mycophenolic acid—systemic scleroderma	0.000349	0.000641	CcSEcCtD
Clonazepam—Mood swings—Methotrexate—systemic scleroderma	0.000348	0.000641	CcSEcCtD
Clonazepam—Nausea—Mometasone—systemic scleroderma	0.000348	0.00064	CcSEcCtD
Clonazepam—Anorexia—Lisinopril—systemic scleroderma	0.000347	0.000639	CcSEcCtD
Clonazepam—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000347	0.000638	CcSEcCtD
Clonazepam—Weight increased—Prednisone—systemic scleroderma	0.000346	0.000637	CcSEcCtD
Clonazepam—Ataxia—Methotrexate—systemic scleroderma	0.000346	0.000636	CcSEcCtD
Clonazepam—Pain—Mycophenolic acid—systemic scleroderma	0.000346	0.000636	CcSEcCtD
Clonazepam—Constipation—Mycophenolic acid—systemic scleroderma	0.000346	0.000636	CcSEcCtD
Clonazepam—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000346	0.000636	CcSEcCtD
Clonazepam—Weight decreased—Prednisone—systemic scleroderma	0.000344	0.000633	CcSEcCtD
Clonazepam—Cough—Mycophenolate mofetil—systemic scleroderma	0.000341	0.000628	CcSEcCtD
Clonazepam—Hypotension—Lisinopril—systemic scleroderma	0.00034	0.000626	CcSEcCtD
Clonazepam—Dizziness—Captopril—systemic scleroderma	0.00034	0.000626	CcSEcCtD
Clonazepam—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00034	0.000625	CcSEcCtD
Clonazepam—Depression—Prednisone—systemic scleroderma	0.000338	0.000622	CcSEcCtD
Clonazepam—Urticaria—Leflunomide—systemic scleroderma	0.000337	0.00062	CcSEcCtD
Clonazepam—Abdominal pain—Leflunomide—systemic scleroderma	0.000335	0.000616	CcSEcCtD
Clonazepam—Body temperature increased—Leflunomide—systemic scleroderma	0.000335	0.000616	CcSEcCtD
Clonazepam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000333	0.000613	CcSEcCtD
Clonazepam—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000612	CcSEcCtD
Clonazepam—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000612	CcSEcCtD
Clonazepam—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000612	CcSEcCtD
Clonazepam—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000332	0.000612	CcSEcCtD
Clonazepam—Breast disorder—Methotrexate—systemic scleroderma	0.000332	0.000612	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000332	0.000611	CcSEcCtD
Clonazepam—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000332	0.00061	CcSEcCtD
Clonazepam—Hypersensitivity—Azathioprine—systemic scleroderma	0.000331	0.000608	CcSEcCtD
Clonazepam—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000331	0.000608	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000608	CcSEcCtD
Clonazepam—Insomnia—Lisinopril—systemic scleroderma	0.000329	0.000606	CcSEcCtD
Clonazepam—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000605	CcSEcCtD
Clonazepam—Vomiting—Captopril—systemic scleroderma	0.000327	0.000602	CcSEcCtD
Clonazepam—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000599	CcSEcCtD
Clonazepam—Dyspnoea—Lisinopril—systemic scleroderma	0.000325	0.000597	CcSEcCtD
Clonazepam—Rash—Captopril—systemic scleroderma	0.000324	0.000597	CcSEcCtD
Clonazepam—Dermatitis—Captopril—systemic scleroderma	0.000324	0.000596	CcSEcCtD
Clonazepam—Somnolence—Lisinopril—systemic scleroderma	0.000324	0.000596	CcSEcCtD
Clonazepam—Headache—Captopril—systemic scleroderma	0.000322	0.000593	CcSEcCtD
Clonazepam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000592	CcSEcCtD
Clonazepam—Dyspepsia—Lisinopril—systemic scleroderma	0.000321	0.00059	CcSEcCtD
Clonazepam—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00032	0.000588	CcSEcCtD
Clonazepam—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00032	0.000588	CcSEcCtD
Clonazepam—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000587	CcSEcCtD
Clonazepam—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000587	CcSEcCtD
Clonazepam—Asthma—Methotrexate—systemic scleroderma	0.000318	0.000585	CcSEcCtD
Clonazepam—Infection—Mycophenolate mofetil—systemic scleroderma	0.000317	0.000583	CcSEcCtD
Clonazepam—Decreased appetite—Lisinopril—systemic scleroderma	0.000317	0.000583	CcSEcCtD
Clonazepam—Eosinophilia—Methotrexate—systemic scleroderma	0.000315	0.000579	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000314	0.000579	CcSEcCtD
Clonazepam—Fatigue—Lisinopril—systemic scleroderma	0.000314	0.000578	CcSEcCtD
Clonazepam—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000576	CcSEcCtD
Clonazepam—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000312	0.000575	CcSEcCtD
Clonazepam—Hypersensitivity—Leflunomide—systemic scleroderma	0.000312	0.000575	CcSEcCtD
Clonazepam—Pain—Lisinopril—systemic scleroderma	0.000311	0.000573	CcSEcCtD
Clonazepam—Constipation—Lisinopril—systemic scleroderma	0.000311	0.000573	CcSEcCtD
Clonazepam—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000311	0.000573	CcSEcCtD
Clonazepam—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00057	CcSEcCtD
Clonazepam—Diarrhoea—Azathioprine—systemic scleroderma	0.000307	0.000565	CcSEcCtD
Clonazepam—Haemoglobin—Prednisone—systemic scleroderma	0.000306	0.000563	CcSEcCtD
Clonazepam—Nausea—Captopril—systemic scleroderma	0.000305	0.000562	CcSEcCtD
Clonazepam—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000305	0.000561	CcSEcCtD
Clonazepam—Haemorrhage—Prednisone—systemic scleroderma	0.000304	0.00056	CcSEcCtD
Clonazepam—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00056	CcSEcCtD
Clonazepam—Asthenia—Leflunomide—systemic scleroderma	0.000304	0.00056	CcSEcCtD
Clonazepam—Hallucination—Prednisone—systemic scleroderma	0.000303	0.000557	CcSEcCtD
Clonazepam—Feeling abnormal—Lisinopril—systemic scleroderma	0.0003	0.000552	CcSEcCtD
Clonazepam—Pruritus—Leflunomide—systemic scleroderma	0.0003	0.000552	CcSEcCtD
Clonazepam—Connective tissue disorder—Prednisone—systemic scleroderma	0.000299	0.00055	CcSEcCtD
Clonazepam—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000549	CcSEcCtD
Clonazepam—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000298	0.000548	CcSEcCtD
Clonazepam—Dysuria—Methotrexate—systemic scleroderma	0.000297	0.000547	CcSEcCtD
Clonazepam—Dizziness—Azathioprine—systemic scleroderma	0.000297	0.000546	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000295	0.000544	CcSEcCtD
Clonazepam—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000293	0.000539	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000535	CcSEcCtD
Clonazepam—Asthenia—Mycophenolic acid—systemic scleroderma	0.00029	0.000534	CcSEcCtD
Clonazepam—Diarrhoea—Leflunomide—systemic scleroderma	0.00029	0.000534	CcSEcCtD
Clonazepam—Urticaria—Lisinopril—systemic scleroderma	0.000289	0.000532	CcSEcCtD
Clonazepam—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000531	CcSEcCtD
Clonazepam—Abdominal pain—Lisinopril—systemic scleroderma	0.000288	0.00053	CcSEcCtD
Clonazepam—Body temperature increased—Lisinopril—systemic scleroderma	0.000288	0.00053	CcSEcCtD
Clonazepam—Pruritus—Mycophenolic acid—systemic scleroderma	0.000286	0.000526	CcSEcCtD
Clonazepam—Vomiting—Azathioprine—systemic scleroderma	0.000285	0.000525	CcSEcCtD
Clonazepam—Pneumonia—Methotrexate—systemic scleroderma	0.000285	0.000525	CcSEcCtD
Clonazepam—Eye disorder—Prednisone—systemic scleroderma	0.000285	0.000524	CcSEcCtD
Clonazepam—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000523	CcSEcCtD
Clonazepam—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000522	CcSEcCtD
Clonazepam—Drowsiness—Methotrexate—systemic scleroderma	0.000283	0.000522	CcSEcCtD
Clonazepam—Rash—Azathioprine—systemic scleroderma	0.000283	0.000521	CcSEcCtD
Clonazepam—Dermatitis—Azathioprine—systemic scleroderma	0.000283	0.00052	CcSEcCtD
Clonazepam—Depression—Methotrexate—systemic scleroderma	0.000283	0.00052	CcSEcCtD
Clonazepam—Flushing—Prednisone—systemic scleroderma	0.000283	0.00052	CcSEcCtD
Clonazepam—Headache—Azathioprine—systemic scleroderma	0.000281	0.000517	CcSEcCtD
Clonazepam—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000517	CcSEcCtD
Clonazepam—Dizziness—Leflunomide—systemic scleroderma	0.00028	0.000516	CcSEcCtD
Clonazepam—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00051	CcSEcCtD
Clonazepam—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000277	0.000509	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000507	CcSEcCtD
Clonazepam—Immune system disorder—Prednisone—systemic scleroderma	0.000275	0.000506	CcSEcCtD
Clonazepam—Pain—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000502	CcSEcCtD
Clonazepam—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000502	CcSEcCtD
Clonazepam—Vomiting—Leflunomide—systemic scleroderma	0.000269	0.000496	CcSEcCtD
Clonazepam—Alopecia—Prednisone—systemic scleroderma	0.000269	0.000495	CcSEcCtD
Clonazepam—Hypersensitivity—Lisinopril—systemic scleroderma	0.000268	0.000494	CcSEcCtD
Clonazepam—Dizziness—Mycophenolic acid—systemic scleroderma	0.000267	0.000492	CcSEcCtD
Clonazepam—Epistaxis—Methotrexate—systemic scleroderma	0.000267	0.000492	CcSEcCtD
Clonazepam—Rash—Leflunomide—systemic scleroderma	0.000267	0.000492	CcSEcCtD
Clonazepam—Dermatitis—Leflunomide—systemic scleroderma	0.000267	0.000491	CcSEcCtD
Clonazepam—Mental disorder—Prednisone—systemic scleroderma	0.000267	0.000491	CcSEcCtD
Clonazepam—Nausea—Azathioprine—systemic scleroderma	0.000267	0.000491	CcSEcCtD
Clonazepam—Headache—Leflunomide—systemic scleroderma	0.000266	0.000489	CcSEcCtD
Clonazepam—Malnutrition—Prednisone—systemic scleroderma	0.000265	0.000488	CcSEcCtD
Clonazepam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000484	CcSEcCtD
Clonazepam—Asthenia—Lisinopril—systemic scleroderma	0.000261	0.000481	CcSEcCtD
Clonazepam—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000261	0.00048	CcSEcCtD
Clonazepam—Pruritus—Lisinopril—systemic scleroderma	0.000258	0.000474	CcSEcCtD
Clonazepam—Vomiting—Mycophenolic acid—systemic scleroderma	0.000257	0.000473	CcSEcCtD
Clonazepam—Haemoglobin—Methotrexate—systemic scleroderma	0.000256	0.000471	CcSEcCtD
Clonazepam—Rash—Mycophenolic acid—systemic scleroderma	0.000255	0.000469	CcSEcCtD
Clonazepam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000255	0.000469	CcSEcCtD
Clonazepam—Haemorrhage—Methotrexate—systemic scleroderma	0.000254	0.000468	CcSEcCtD
Clonazepam—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000466	CcSEcCtD
Clonazepam—Headache—Mycophenolic acid—systemic scleroderma	0.000253	0.000466	CcSEcCtD
Clonazepam—Pharyngitis—Methotrexate—systemic scleroderma	0.000253	0.000465	CcSEcCtD
Clonazepam—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000464	CcSEcCtD
Clonazepam—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000464	CcSEcCtD
Clonazepam—Nausea—Leflunomide—systemic scleroderma	0.000252	0.000463	CcSEcCtD
Clonazepam—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000251	0.000462	CcSEcCtD
Clonazepam—Vision blurred—Prednisone—systemic scleroderma	0.00025	0.00046	CcSEcCtD
Clonazepam—Urethral disorder—Methotrexate—systemic scleroderma	0.000249	0.000459	CcSEcCtD
Clonazepam—Diarrhoea—Lisinopril—systemic scleroderma	0.000249	0.000458	CcSEcCtD
Clonazepam—Ill-defined disorder—Prednisone—systemic scleroderma	0.000246	0.000452	CcSEcCtD
Clonazepam—Visual impairment—Methotrexate—systemic scleroderma	0.000245	0.000451	CcSEcCtD
Clonazepam—Anaemia—Prednisone—systemic scleroderma	0.000245	0.000451	CcSEcCtD
Clonazepam—Agitation—Prednisone—systemic scleroderma	0.000244	0.000448	CcSEcCtD
Clonazepam—Angioedema—Prednisone—systemic scleroderma	0.000242	0.000446	CcSEcCtD
Clonazepam—Dizziness—Lisinopril—systemic scleroderma	0.000241	0.000443	CcSEcCtD
Clonazepam—Nausea—Mycophenolic acid—systemic scleroderma	0.00024	0.000442	CcSEcCtD
Clonazepam—Malaise—Prednisone—systemic scleroderma	0.000239	0.00044	CcSEcCtD
Clonazepam—Vertigo—Prednisone—systemic scleroderma	0.000238	0.000438	CcSEcCtD
Clonazepam—Eye disorder—Methotrexate—systemic scleroderma	0.000238	0.000438	CcSEcCtD
Clonazepam—Cardiac disorder—Methotrexate—systemic scleroderma	0.000236	0.000434	CcSEcCtD
Clonazepam—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000433	CcSEcCtD
Clonazepam—Vomiting—Lisinopril—systemic scleroderma	0.000232	0.000426	CcSEcCtD
Clonazepam—Immune system disorder—Methotrexate—systemic scleroderma	0.00023	0.000423	CcSEcCtD
Clonazepam—Rash—Lisinopril—systemic scleroderma	0.00023	0.000423	CcSEcCtD
Clonazepam—Dermatitis—Lisinopril—systemic scleroderma	0.000229	0.000422	CcSEcCtD
Clonazepam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000421	CcSEcCtD
Clonazepam—Chills—Methotrexate—systemic scleroderma	0.000228	0.00042	CcSEcCtD
Clonazepam—Headache—Lisinopril—systemic scleroderma	0.000228	0.00042	CcSEcCtD
Clonazepam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000415	CcSEcCtD
Clonazepam—Arthralgia—Prednisone—systemic scleroderma	0.000226	0.000415	CcSEcCtD
Clonazepam—Myalgia—Prednisone—systemic scleroderma	0.000226	0.000415	CcSEcCtD
Clonazepam—Anxiety—Prednisone—systemic scleroderma	0.000225	0.000414	CcSEcCtD
Clonazepam—Alopecia—Methotrexate—systemic scleroderma	0.000225	0.000414	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000224	0.000412	CcSEcCtD
Clonazepam—Discomfort—Prednisone—systemic scleroderma	0.000223	0.00041	CcSEcCtD
Clonazepam—Mental disorder—Methotrexate—systemic scleroderma	0.000223	0.00041	CcSEcCtD
Clonazepam—Malnutrition—Methotrexate—systemic scleroderma	0.000221	0.000408	CcSEcCtD
Clonazepam—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000402	CcSEcCtD
Clonazepam—Nausea—Lisinopril—systemic scleroderma	0.000216	0.000398	CcSEcCtD
Clonazepam—Anaphylactic shock—Prednisone—systemic scleroderma	0.000216	0.000398	CcSEcCtD
Clonazepam—Oedema—Prednisone—systemic scleroderma	0.000216	0.000398	CcSEcCtD
Clonazepam—Infection—Prednisone—systemic scleroderma	0.000215	0.000395	CcSEcCtD
Clonazepam—Back pain—Methotrexate—systemic scleroderma	0.000214	0.000394	CcSEcCtD
Clonazepam—Nervous system disorder—Prednisone—systemic scleroderma	0.000212	0.00039	CcSEcCtD
Clonazepam—Tachycardia—Prednisone—systemic scleroderma	0.000211	0.000388	CcSEcCtD
Clonazepam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000388	CcSEcCtD
Clonazepam—Skin disorder—Prednisone—systemic scleroderma	0.00021	0.000387	CcSEcCtD
Clonazepam—Vision blurred—Methotrexate—systemic scleroderma	0.000209	0.000384	CcSEcCtD
Clonazepam—Anorexia—Prednisone—systemic scleroderma	0.000206	0.000379	CcSEcCtD
Clonazepam—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000206	0.000378	CcSEcCtD
Clonazepam—Anaemia—Methotrexate—systemic scleroderma	0.000205	0.000377	CcSEcCtD
Clonazepam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000373	CcSEcCtD
Clonazepam—Rash—Mycophenolate mofetil—systemic scleroderma	0.000201	0.00037	CcSEcCtD
Clonazepam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000201	0.00037	CcSEcCtD
Clonazepam—Headache—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000368	CcSEcCtD
Clonazepam—Malaise—Methotrexate—systemic scleroderma	0.0002	0.000368	CcSEcCtD
Clonazepam—Vertigo—Methotrexate—systemic scleroderma	0.000199	0.000366	CcSEcCtD
Clonazepam—Leukopenia—Methotrexate—systemic scleroderma	0.000198	0.000365	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000197	0.000363	CcSEcCtD
Clonazepam—Insomnia—Prednisone—systemic scleroderma	0.000196	0.00036	CcSEcCtD
Clonazepam—Cough—Methotrexate—systemic scleroderma	0.000193	0.000356	CcSEcCtD
Clonazepam—Dyspepsia—Prednisone—systemic scleroderma	0.00019	0.00035	CcSEcCtD
Clonazepam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000349	CcSEcCtD
Clonazepam—Arthralgia—Methotrexate—systemic scleroderma	0.000189	0.000347	CcSEcCtD
Clonazepam—Chest pain—Methotrexate—systemic scleroderma	0.000189	0.000347	CcSEcCtD
Clonazepam—Myalgia—Methotrexate—systemic scleroderma	0.000189	0.000347	CcSEcCtD
Clonazepam—Decreased appetite—Prednisone—systemic scleroderma	0.000188	0.000346	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000187	0.000345	CcSEcCtD
Clonazepam—Fatigue—Prednisone—systemic scleroderma	0.000186	0.000343	CcSEcCtD
Clonazepam—Discomfort—Methotrexate—systemic scleroderma	0.000186	0.000343	CcSEcCtD
Clonazepam—Constipation—Prednisone—systemic scleroderma	0.000185	0.00034	CcSEcCtD
Clonazepam—Confusional state—Methotrexate—systemic scleroderma	0.000182	0.000335	CcSEcCtD
Clonazepam—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000181	0.000333	CcSEcCtD
Clonazepam—Infection—Methotrexate—systemic scleroderma	0.00018	0.00033	CcSEcCtD
Clonazepam—Feeling abnormal—Prednisone—systemic scleroderma	0.000178	0.000328	CcSEcCtD
Clonazepam—Nervous system disorder—Methotrexate—systemic scleroderma	0.000177	0.000326	CcSEcCtD
Clonazepam—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000177	0.000326	CcSEcCtD
Clonazepam—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000177	0.000325	CcSEcCtD
Clonazepam—Skin disorder—Methotrexate—systemic scleroderma	0.000176	0.000323	CcSEcCtD
Clonazepam—Anorexia—Methotrexate—systemic scleroderma	0.000172	0.000317	CcSEcCtD
Clonazepam—Urticaria—Prednisone—systemic scleroderma	0.000172	0.000316	CcSEcCtD
Clonazepam—Body temperature increased—Prednisone—systemic scleroderma	0.000171	0.000315	CcSEcCtD
Clonazepam—Abdominal pain—Prednisone—systemic scleroderma	0.000171	0.000315	CcSEcCtD
Clonazepam—Hypotension—Methotrexate—systemic scleroderma	0.000169	0.000311	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000165	0.000303	CcSEcCtD
Clonazepam—Insomnia—Methotrexate—systemic scleroderma	0.000163	0.000301	CcSEcCtD
Clonazepam—Dyspnoea—Methotrexate—systemic scleroderma	0.000161	0.000297	CcSEcCtD
Clonazepam—Somnolence—Methotrexate—systemic scleroderma	0.000161	0.000296	CcSEcCtD
Clonazepam—Hypersensitivity—Prednisone—systemic scleroderma	0.000159	0.000293	CcSEcCtD
Clonazepam—Dyspepsia—Methotrexate—systemic scleroderma	0.000159	0.000293	CcSEcCtD
Clonazepam—Decreased appetite—Methotrexate—systemic scleroderma	0.000157	0.000289	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000156	0.000287	CcSEcCtD
Clonazepam—Fatigue—Methotrexate—systemic scleroderma	0.000156	0.000287	CcSEcCtD
Clonazepam—Asthenia—Prednisone—systemic scleroderma	0.000155	0.000286	CcSEcCtD
Clonazepam—Pain—Methotrexate—systemic scleroderma	0.000155	0.000284	CcSEcCtD
Clonazepam—Pruritus—Prednisone—systemic scleroderma	0.000153	0.000282	CcSEcCtD
Clonazepam—Feeling abnormal—Methotrexate—systemic scleroderma	0.000149	0.000274	CcSEcCtD
Clonazepam—Diarrhoea—Prednisone—systemic scleroderma	0.000148	0.000272	CcSEcCtD
Clonazepam—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000148	0.000272	CcSEcCtD
Clonazepam—Urticaria—Methotrexate—systemic scleroderma	0.000144	0.000264	CcSEcCtD
Clonazepam—Dizziness—Prednisone—systemic scleroderma	0.000143	0.000263	CcSEcCtD
Clonazepam—Body temperature increased—Methotrexate—systemic scleroderma	0.000143	0.000263	CcSEcCtD
Clonazepam—Abdominal pain—Methotrexate—systemic scleroderma	0.000143	0.000263	CcSEcCtD
Clonazepam—Vomiting—Prednisone—systemic scleroderma	0.000138	0.000253	CcSEcCtD
Clonazepam—Rash—Prednisone—systemic scleroderma	0.000136	0.000251	CcSEcCtD
Clonazepam—Dermatitis—Prednisone—systemic scleroderma	0.000136	0.000251	CcSEcCtD
Clonazepam—Headache—Prednisone—systemic scleroderma	0.000136	0.000249	CcSEcCtD
Clonazepam—Hypersensitivity—Methotrexate—systemic scleroderma	0.000133	0.000245	CcSEcCtD
Clonazepam—Asthenia—Methotrexate—systemic scleroderma	0.00013	0.000239	CcSEcCtD
Clonazepam—Nausea—Prednisone—systemic scleroderma	0.000128	0.000236	CcSEcCtD
Clonazepam—Pruritus—Methotrexate—systemic scleroderma	0.000128	0.000235	CcSEcCtD
Clonazepam—Diarrhoea—Methotrexate—systemic scleroderma	0.000124	0.000228	CcSEcCtD
Clonazepam—Dizziness—Methotrexate—systemic scleroderma	0.00012	0.00022	CcSEcCtD
Clonazepam—Vomiting—Methotrexate—systemic scleroderma	0.000115	0.000211	CcSEcCtD
Clonazepam—Rash—Methotrexate—systemic scleroderma	0.000114	0.00021	CcSEcCtD
Clonazepam—Dermatitis—Methotrexate—systemic scleroderma	0.000114	0.00021	CcSEcCtD
Clonazepam—Headache—Methotrexate—systemic scleroderma	0.000113	0.000208	CcSEcCtD
Clonazepam—Nausea—Methotrexate—systemic scleroderma	0.000107	0.000198	CcSEcCtD
